Post is total ALKON manure.
Don't worry, we promise to start trials after NTRP fails ALZ the second time.
Shareholders, please keep voting for further dilution.
Even though Fragile X was granted orphan designation in 2015, we promise to actually "initiate" the trial after the Alz trial fails again in 2019.
Shareholders, please keep voting for further dilution despite our failures!
MS trial anyday now!
ALKON and RYAN need haircuts and printing press money.
Market Data 
Markets 
AI
